Annals of medicine
Weber B, Roth R.
PMID: 9453295
Ann Med. 1997 Oct;29(5):461-7. doi: 10.3109/07853899708999377.
Growing understanding of the pathogenetic process of insulin-dependent diabetes mellitus diabetes has favoured attempts to predict the clinical manifestation of the metabolic disorder in people at risk by some easily measurable marker or markers and, subsequently, to prevent its...
Cite
Weber B, Roth R. Psychological aspects in diabetes prevention trials. Ann Med. 1997;29(5):461-7doi: 10.3109/07853899708999377.
Weber, B., & Roth, R. (1997). Psychological aspects in diabetes prevention trials. Annals of medicine, 29(5), 461-7. https://doi.org/10.3109/07853899708999377
Weber, B, and Roth, R. "Psychological aspects in diabetes prevention trials." Annals of medicine vol. 29,5 (1997): 461-7. doi: https://doi.org/10.3109/07853899708999377
Weber B, Roth R. Psychological aspects in diabetes prevention trials. Ann Med. 1997 Oct;29(5):461-7. doi: 10.3109/07853899708999377. PMID: 9453295.
Copy
Download .nbib
Journal of pediatric endocrinology & metabolism : JPEM
Roth R.
PMID: 11393561
J Pediatr Endocrinol Metab. 2001;14:669-74. doi: 10.1515/jpem.2001.14.s1.669.
Advances in immunological and genetic tests and in therapeutics may soon make it possible to predict, prevent or delay the development of type 1 diabetes mellitus (DM). Psychological support should be available at every stage of the screening and...
Cite
Roth R. Psychological and ethical aspects of prevention trials. J Pediatr Endocrinol Metab. 2001;14:669-74doi: 10.1515/jpem.2001.14.s1.669.
Roth, R. (2001). Psychological and ethical aspects of prevention trials. Journal of pediatric endocrinology & metabolism : JPEM, 14669-74. https://doi.org/10.1515/jpem.2001.14.s1.669
Roth, R. "Psychological and ethical aspects of prevention trials." Journal of pediatric endocrinology & metabolism : JPEM vol. 14 (2001): 669-74. doi: https://doi.org/10.1515/jpem.2001.14.s1.669
Roth R. Psychological and ethical aspects of prevention trials. J Pediatr Endocrinol Metab. 2001;14:669-74. doi: 10.1515/jpem.2001.14.s1.669. PMID: 11393561.
Copy
Download .nbib
Lancet (London, England)
Kumar PD.
PMID: 1347889
Lancet. 1992 Apr 04;339(8797):876. doi: 10.1016/0140-6736(92)90324-v.
No abstract available.
Cite
Kumar PD. Hazards of clinical trials. Lancet. 1992;339(8797):876doi: 10.1016/0140-6736(92)90324-v.
Kumar, P. D. (1992). Hazards of clinical trials. Lancet (London, England), 339(8797), 876. https://doi.org/10.1016/0140-6736(92)90324-v
Kumar, P D. "Hazards of clinical trials." Lancet (London, England) vol. 339,8797 (1992): 876. doi: https://doi.org/10.1016/0140-6736(92)90324-v
Kumar PD. Hazards of clinical trials. Lancet. 1992 Apr 04;339(8797):876. doi: 10.1016/0140-6736(92)90324-v. PMID: 1347889.
Copy
Download .nbib
